Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding motif protein 8A (RBM8A) is a conserved RNA-binding protein predominantly found in the nucleus, functioning as a core component of the exon junction complex (EJC). RBM8A is crucial in post-transcriptional mRNA processing, including mRNA splicing, transport, surveillance (notably nonsense-mediated decay), and regulation of stability/mRNA degradation. It helps carry mRNA from the nucleus to the cytoplasm and associates with spliced mRNAs to mark exon junctions, thereby facilitating correct gene expression. Loss-of-function mutations or deletions in RBM8A lead to thrombocytopenia-absent radius syndrome (TAR), a rare congenital disorder, and abnormal RBM8A expression is linked to several cancers and neurodevelopmental conditions[1][4][7][9][13]. No drugs directly target RBM8A, and inhibition is not compatible with life, underscoring its essential cellular function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding motif protein 8A (RBM8A).